










AddOxidative stress precedes skeletal muscle
mitochondrial dysfunction during experimental
aortic cross-clamping but is not associated with
early lung, heart, brain, liver, or kidney
mitochondrial impairment
Max Guillot, MD,a,b Anne-Laure Charles, PhD,a,c Thien Nga Chamaraux-Tran, MD,a,d
Jamal Bouitbir, PhD,e Alain Meyer, MD,a,c Joffrey Zoll, PhD,a,c Francis Schneider, MD, PhD,b and
Bernard Geny, MD, PhD,a,c Strasbourg, France; and Basel, Switzerland
Objective: Lower limb ischemia-reperfusion results in skeletal muscle mitochondrial alterations, production of reactive
oxygen species (ROS), and remote organ impairments that are largely involved in patient prognosis. However, whether
ischemia without reperfusion increases ROS production and precedes mitochondrial alteration and whether mitochon-
drial dysfunction occurs early in remote organs is unknown. This study determined muscle mitochondrial function and
ROS production after ischemia alone, or followed by two periods of reperfusion, and investigated heart, lung, liver,
kidney, and brain mitochondrial functions after lower limb ischemia-reperfusion.
Methods: Wistar rats were randomized into four groups: sham (aortic exposure but no ischemia, n [ 9), I3 (ischemia
alone induced by aortic cross-clamping for 3 hours, n[ 9), I3R100 and I3R2 (aortic cross-clamping, followedby reperfusion
for 10 minutes [n [ 8] or 2 hours [n [ 9]). Blood lactate, alanine aminotransferase, aspartate aminotransferase, and
creatinine weremeasured.Mitochondrial respiratory chain complexes I, II, III, and IV activities andmitochondrial coupling
(acceptor control ratio) were analyzed using a Clark oxygen electrode in skeletal muscle, lung, heart, brain, liver, and kidney.
ROS production was determined using dihydroethidium staining in muscle, heart, liver, and kidney. Inﬂammation was also
investigated in remote organs (heart, liver, and kidney) using monocyte-macrophage-2 antibody staining.
Results: Lactate level increased after ischemia in all groups. In muscle, ROS increased signiﬁcantly after ischemia alone
(D324% 6 66%; P [ .038), normalized after 10 minutes of reperfusion, and increased again at 2 hours of reperfusion
(D349.2 6 67%; P [ .024). Interestingly, mitochondrial function was unaffected by ischemia alone or followed by
10 minutes of reperfusion, but maximal mitochondrial oxidative capacity (6.10 6 0.51 vs 4.24 6 0.36 mmol/min/g,
L30%; P < .05) and mitochondrial coupling decreased after 2 hours of reperfusion (1.93 6 0.17 vs 1.33 6 0.07,L45%;
P < .01), in sham and I3R2 rats, respectively. Despite increased serum aspartate aminotransferase (313; P < .0001),
alanine aminotransferase (36; P[ .0019), and creatinine (33; P[ .0004), remote organs did not show mitochondrial
alteration, inﬂammation, or ROS production enhancement after 2 hours of reperfusion.
Conclusions:Oxidative stress precedes skeletal muscle mitochondrial dysfunction during lower limb ischemia. Such a kinetic
explains the efﬁcacy of ischemic preconditioning and supports that therapy should be conducted even during ongoing
ischemia, suggesting that ischemic preconditioning might be a successful approach. (J Vasc Surg 2014;60:1043-51.)
Clinical Relevance: Aortic cross-clamping increases reactive oxygen species (ROS) and impairs skeletal muscle and remote
organs, which is involved in patient prognosis. However, the temporal relationship between ROS production and
mitochondrial dysfunction during lower limb ischemia reperfusion is unknown. This study demonstrates for the ﬁrst time
that ROS production occurs during ischemia alone, without reperfusion, and precedes skeletal muscle mitochondrial
impairments. Although involved in multiorgan failure, lung, heart, brain, liver, and kidney mitochondria are not affected
early. These results support a need for muscle protection even during lower limb ischemia and that ischemic pre-
conditioning (conditioning performed during ongoing ischemia) might be a successful approach.Aortic cross-clamping is often performed in the setting
of vascular surgery, such as abdominal aortic aneurysm
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morbidities.1-4
Key factors involved in the deleterious effects of lower
limb ischemia-reperfusion (IR) are increased oxidative
stress and impaired mitochondrial functions.5-7 Increased
reactive oxygen species (ROS) production is known to alter
cell lipids, proteins, and DNA and to mediate mitochon-
drial dysfunction in skeletal muscles. In turn, impaired
mitochondria enhance their production of ROS in a vicious
cycle in which mitochondria are both the target and origin
of increased oxidative stress.8
A better knowledge on the precise temporal relation-
ship between mitochondrial dysfunction and increased
ROS production is mandatory to improve muscle protec-
tion. The precise kinetic of alteration of the respiratory
chain and free-radical production is not known during
lower limb IR. Production of ROS occurs in response to
ischemia at the time of reperfusion,9 but whether ROS
might arise early during ischemia without reperfusion in
skeletal muscle remains an unresolved issue. Similarly,
mitochondrial dysfunction occurs after ischemia of
>5 hours or after 3 hours of ischemia, followed by 2 hours
of reperfusion,7,9,10 but whether mitochondrial dysfunc-
tion occurs during shorter-term ischemia without reperfu-
sion is not known.
Another interesting issue is remote organ impairments.
Although remote organ impairment participates greatly in
patient prognosis,1-4 few experiments have investigated
potential remote organ alterations at the mitochondrial
level after lower limb IR. In view of its clinical importance,
mitochondrial dysfunction, often leading to organ dysfunc-
tion and ultimately to multiorgan failure syndrome,11 and
main organ mitochondrial function after aortic cross-
clamping and reperfusion deserve to be studied to develop
and compare the effectiveness of clinical strategies to
reduce cardiovascular and other perioperative complica-
tions after vascular interventions.12
The ﬁrst objective of our study was therefore to deter-
mine simultaneously the kinetics of ROS production and
mitochondrial respiration changes in four experimental
settings, challenging the hypothesis that ROS production
might occur in skeletal muscle during ischemia alone and
might precede mitochondrial dysfunction. Further, we
investigated whether aortic cross-clamping impairs ﬁve
main organs involved in multiorgan failuredlung, heart,
brain, liver, and kidneydthrough a combination of bio-
logic, histologic, and mitochondrial function analysis.
METHODS
The investigations in this study were performed in
accordance with the Helsinki Accords for Humane Treat-
ment of Animals During Experimentation. We obtained
approval from the Comité régional d’éthique en matière
d’expérimentation animale (CREMEAS), the ethics com-
mittee on animal research.
Study animals. The study was performed in adult
male Wistar rats (250 to 350 g). The rats were housed
in a thermoneutral environment of 22 6 2C on a12-hour day/night cycle and were provided food and
water ad libitum.
Preoperative management. Rats were placed in
a hermetic cage for induction of anesthesia and ventilated
with a mixture of 4% isoﬂurane (Centre Spécialités Pharma-
ceutiques, Cournon, France) and oxygen. After induction,
rats were placed on heating blankets (Equipement Vétérin-
aire Minerve SA, Esternay, France), with a preselected
35C temperature maintained during the entire procedure.
Spontaneous ventilation was allowed through an oxygen-
delivering mask, with concentrations of isoﬂurane adapt-
ed to the surgical phases. A rectal probe was inserted for
continuous temperature monitoring, and three electrodes
were placed for electrocardiographic monitoring.
Experimental design and surgical procedure. Rats
were divided into four groups. The sham group (n ¼ 9)
had no ischemia but underwent anesthesia, and a midline
laparotomy was performed. The posterior peritoneum
was cut to expose the abdominal aorta and the inferior
vena cava. The infrarenal abdominal aorta was dissected
and liberated from adjacent adhesions in all animals. The
ischemia-alone group (I3, n ¼ 9) underwent 3 hours of
ischemia induced by infrarenal aortic occlusion, and arterial
collaterals located between the renal arteries and the aortic
bifurcation were coagulated using a Geiger Thermal
Cautery Unit (Geiger Medical Technologies, Council
Bluffs, Iowa) and cut.
The two IR groups also underwent 3 hours of
ischemia, followed by reperfusion for 10 minutes
(I3R100, n ¼ 8) or 2 hours (I3R2, n ¼ 9). The aorta
was temporally occluded using a DeBakey Cross-Action
Bulldog Clamp, as reported in previous experiments.9,10,13
After aortic clamping, the abdomen was tightly closed to
avoid dehydration. Ischemia was clinically characterized
by cyanosis and lack of arterial pulse distal to the clamp
and was also ascertained by capillary lactate measurement
on the tail (Lactate Pro; Arkray SAS, Paris France).
At the end of the experiment, the right gastrocnemius
muscle was dissected for immediate mitochondrial function
analysis. Part of the muscle was also cryopreserved for ROS
production determination.
Detection of ROS. To detect the presence of ROS in
skeletal muscle, heart, kidney, and liver, serial 10-mm
sections were cut on a cryostat microtome, mounted onto
glass slides, and incubated with 2.5 mmol/L dihydroethi-
dium (DHE)14,15 (Supplementary Methods, online only).
Immunohistochemical procedure. To detect inﬂam-
mation in heart, kidney, and liver in the sham and I3R2
groups at the end of experiment, we used monocyte-
macrophage-2 antibody (Millipore, Billerica, Mass) on
10-mm-thick serial sections of tisuse10 (Supplementary
Methods, online only).
Permeabilization of muscle and heart ﬁbers and
isolation of mitochondria in lung, heart, brain, liver,
and kidney. Mitochondrial respiration was studied in
saponin-skinned ﬁbers, as previously described.16,17 Lung,
heart, brain, liver, and kidney mitochondria were isolated
on ice, homogenized, and centrifuged. Aliquots were then
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(Biomate 3; Thermo Fisher Scientiﬁc Inc, Waltham, Mass)
(Supplementary Methods, online only).
Study of activities of muscle mitochondrial respi-
ratory chain complexes and mitochondrial coupling.
Measuring oxygen consumption in skinned ﬁbers is
a unique technique to determine the oxidative capacity of
the skeletal muscle in its cellular environment, and
mitochondrial oxygen consumption is measured polaro-
graphically by using a Clark-type electrode (Strathkelvin
Instruments, Glasgow, Scotland) and expressed in micro-
moles of oxygen consumed per minute reported on the dry
weight of muscle sample (mmol/min/g). The relative
contribution of the respiratory chain complexes I, II, III,
and IV to the global mitochondrial respiratory rate can be
studied using different substrates.
First, basal respiration (V0) with glutamate and malate
as substrates was analyzed. Then, maximal ﬁbers respiration
(Vmax) was recorded after adding adenosine diphosphate
(ADP). In this case, electron ﬂow went through complexes
I, III, and IV because of the presence of glutamate
(5 mmol/L) and malate (2 mmol/L).
Thereafter, complex I was blocked with amobarbital
(0.02 mmol/L), and complex II was stimulated with
succinate (25 mmol/L). Mitochondrial respiration in these
conditions allowed the investigation of complexes II, III,
and IV activities (Vsucc).
Finally,N,N,N’,N’-tetramethyl-p-phenylenediamine di-
hydrochloride (TMPD, 0.5 mmol/L) and ascorbate (0.5
mmol/L) were added as an artiﬁcial electron donor to
complex IV. Complex IV activity was then determined as
an isolated step of the respiratory chain (Vtmpd).
Mitochondrial coupling (coupling of phosphorylation
to oxidation) was determined by calculating the acceptor
control ratio (ACR), the ratio between ADP-stimulated
respiration (Vmax) over basal respiration (V0)9,10,13
(Supplementary Fig 1, online only).
Serum alanine aminotransferase, aspartate amino-
transferase, and creatinine levels. The blood samples
were analyzed by automatic ADVIA 2400 (SiemensMedical
Solutions Diagnostics, Tarrytown, NY) to determine the
biochemical plasmatic measures of alanine aminotransferase
(ALAT), aspartate aminotransferase (ASAT), and creatinine
in the sham and I3R2 groups at the end of the experiment.
Statistical analysis. Results were compared among the
four groups using one-way analysis of variance with a least
signiﬁcant differences post-test. GraphPad Prism software
(GraphPad Software Inc, San Diego, Calif) was used for
analysis. Results are shown as mean 6 standard error of the
mean. Results with a value of P < .05 were considered
statistically signiﬁcant.
RESULTS
Lactate production in the four experimental
groups. As expected, we observed a similar and signiﬁcant
increase of lactate at the end of the 3 hours of ischemia in
the groups I3, I3R100, and I3R2, compared with the shamgroup (P < .0001). Thus, the lactate level was 2.14 6
0.85 mM in the sham group and 14.19 6 0.78, 13.77 6
1.27, and 17.90 6 1.29 mM, respectively, in the I3,
I3R100, and I3R2groups (SupplementaryFig 2, onlineonly).
Production of ROS in skeletal muscle during IR.
IR is known to produce ROS in skeletal muscle, but ROS
kinetics remain to be determined. We found a signiﬁcant
increase in DHE staining in the group sustaining ischemia
alone, without reperfusion (I3), compared with sham.
Thus, ROS production in skeletal muscle increased by
324.2% 6 66.24%, as inferred from the ﬂuorescence
emitted in the I3 group (P ¼ .038).
Interestingly, DHE staining decreased when ischemia
was followed by 10 minutes of reperfusion. Thus, the ﬂuo-
rescence emitted in the I3R100 group (146.9% 6 29.76%)
was not different from sham values (P ¼ .92).
Finally, when ischemia was followed by 2 hours of
reperfusion, ROS production in the I3R2 group increased
by 349.2% 6 66.66% (P ¼ .024) compared with the sham
group.
Taken together, these data demonstrate that lower
limb IR secondary to aortic clamping is characterized by
a biphasic pattern, with both an early and a late increase
in ROS production (Fig 1).
Activities of muscle mitochondrial respiratory chain
complexes and coupling decreased only after 3 hours
of ischemia, followed by 2 hours of reperfusion. We
observed an alteration in maximal oxidative capacity
(Vmax) only in the group I3R2. The sham, I3, and
I3R100 groups had a similar Vmax of 6.10 6 0.51,
6.24 6 0.44, and 5.82 6 0.49 mmol/min/g. Therefore,
no difference was induced by ischemia alone or by ischemia
followed by a short-term reperfusion period. However,
2 hours of reperfusion after ischemia decreased signiﬁcantly
the Vmax, relying on complexes I, III, and IV of the mito-
chondrial respiratory chain (4.24 6 0.36 mmol/min/g
in I3R2; P ¼ .03 vs SHAM and P ¼ .018 vs I3).
The study of oxygen consumption after stimulation of
the complex II by the injection of succinate (Vsucc) did
not show any differences among the four groups (P ¼
.27). After injection of succinate, the sham, I3, I3R100,
and I3R2 groups had a mitochondrial oxygen consumption
of, respectively, 5.12 6 0.52, 4.76 6 0.29, 4.14 6 0.37,
and 4.31 6 0.28 mmol/min/g. Thus, consistent with
previous data,10 complexes II, III, and IV of the mitoch-
ondrial respiratory chain appeared more resistant than
complex I when exposed to IR.
We found similar results for complex IV (10.64 6
1.021 mmol/min/g in sham, 12.12 6 0.81 mmol/min/g
in I3, 12.78 6 1.16 mmol/min/g in I3R100, and
8.81 6 0.47 mmol/min/g in I3R2). The decrease in
Vtmpd in group I3R2 compared with group I3R100
(P ¼ .018) was likely due to the nonsigniﬁcant increase
in mitochondrial respiration after 10 minutes of reperfu-
sion compared with sham values.
Finally, we analyzed the ACR, deﬁned by the ratio of
ADP-induced oxygen consumption to the basal rate in
the absence of ADP. We observed a signiﬁcant alteration
Fig 1. Ischemia alone and ischemia followed by 2 hours of reperfusion enhance reactive oxygen species (ROS)
production in skeletal muscles. a, Dihydroethidium (DHE) ﬂuorescence intensity (expressed as percentage of sham
group). The error bars indicate the standard error of the mean. *P < .05. b, Examples of DHE staining. I3, 3 hours of
ischemia; I3R10 0, 3 hours of ischemia, followed by 10 minutes of reperfusion; I3R2, 3 hours of ischemia, followed
2 hours of reperfusion.
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(P ¼ .009), group I3 (P ¼ .038), and group I3R100 (P ¼
.0017). ACR was 1.937 6 0.1776 in the sham group,
1.83 6 0.121 in group I3, 2.072 6 0.11 in group
I3R100, and 1.33 6 0.073 in group I3R2.Taken together, these results support that the mito-
chondrial respiratory chain at the level of complex I and
that mitochondrial coupling is impaired, but only after
3 hours of ischemia, followed by 2 hours of reperfusion
(Fig 2).
Fig 2. Impaired mitochondrial maximal oxidative capacity and mitochondrial coupling after 3 hours of ischemia and
2 hours of reperfusion. a, Maximal ﬁber mitochondrial respiration rates (Vmax) in complexes I, III, and IV. b,
Combined activity of mitochondrial complexes II, III, and IV after stimulation with succinate (Vsucc). c, Complex IV
activity after stimulation with N,N,N’,N’-tetramethyl-p-phenylenediamine dihydrochloride (Vtmpd). d, Acceptor
control ratio (ACR). The error bars indicate the standard error of the mean. I3, 3 hours of ischemia; I3R10 0, 3 hours of
ischemia, followed by 10 minutes of reperfusion; I3R2, 3 hours of ischemia, followed 2 hours of reperfusion.*P < .05;
**P < .01.
JOURNAL OF VASCULAR SURGERY
Volume 60, Number 4 Guillot et al 1047Remote organs mitochondrial function was not
impaired. Results are shown in Fig 3. We did not ﬁnd any
alteration of the mitochondrial respiratory chain complex
activities in the different remote organs analyzed. Maximal
oxygen mitochondrial consumptions (Vmax) were the
same in the sham and I3R2 groups in lung (18.85 6 2.46
vs 19.89 6 1.03 mmol/min/g; P ¼ .69), heart (125.0 6
13.86 vs 110.6 6 7.02 mmol/min/g; P ¼ .35), brain
(35.83 6 5.18 vs 34.77 6 2.76 mmol/min/g; P ¼ .86),
liver (56.90 6 6.32 vs 61.39 6 3.33 mmol/min/g; P ¼
.56), and kidney (93.98 6 8.45 vs 112.5 6 8.9 mmol/
min/g; P ¼ .15).
Similarly, stimulation of complex II with succinate
(Vsucc) did not show any difference between the sham
and I3R2 groups in lung (20.44 6 2.21 vs 21.34 6
1.3 mmol/min/g; P ¼ .79), heart (95.45 6 7.89 vs
88.23 6 4.59 mmol/min/g; P ¼ .59), brain (33.22 6
3.68 vs 32.96 6 1.7 mmol/min/g; P ¼ .72), liver
(55.2 6 21.13 vs 61.89 6 12.89 mmol/min/g; P ¼
.45), and kidney (123.5 6 8.57 vs 139.3 6 7.87 mmol/
min/g; P ¼ .19).
Oxygen mitochondrial consumption after stimulation
of complex IV (Vtmpd) was also the same in the sham
and I3R2 groups in lung (45.52 6 3.36 vs 49.84 62.97 mmol/min/g; P ¼ .51), heart (241.0 6 20.01 vs
220.5 6 12.57 mmol/min/g; P ¼ .59), brain (82.60 6
6.42 vs 79.59 6 5.5 mmol/min/g; P ¼ .72), liver
(79.80 6 8.3 vs 91.81 6 5.12 mmol/min/g; P ¼ .23),
and kidney (207.9 6 13.21 vs 227.0 6 13.89 mmol/
min/g; P ¼ .69).
ROS production in remote organs was not
increased. Compared with the sham group, there was no
signiﬁcant increase in ROS production in heart (86 6
27%; P ¼ .74), kidney (105 6 79%; P ¼ .96), or liver
(34 6 29%; P ¼ .29) after 3 hours of ischemia and 2 hours
of reperfusion (Supplementary Fig 3, online only).
Remote organ inﬂammation was increased in the
liver. We did not ﬁnd tissue histologic alteration, such as
necrosis in heart, kidney, and liver, after IR, but liver
demonstrated monocyte and macrophages inﬁltration
after 3 hours of ischemia and 2 hours of reperfusion
(Supplementary Fig 4, online only).
ALAT, ASAT, and creatinine increased after IR.
Compared with sham, IR induced a signiﬁcant increase of
ASAT (97 6 7 U/L vs 1293 6 130 U/L; P < .0001),
ALAT (52 6 5 U/L vs 330 6 55 U/L; P ¼ .0019),
and creatinine (36 6 4 mmol/L vs 106 6 10 mmol/L;
P ¼ .0004; Supplementary Fig 5, online only).
Fig 3. Lack of deleterious effects of lower limb ischemia-reperfusion (IR) on lung, heart, brain, liver, and kidney
mitochondrial respiratory chain complexes I, II, III, and IV activities. Volume of mitochondrial oxygen consumption
(Vo2) in (a) lung, (b) heart, (c) brain, (d) liver, and (e) kidney. I3, 3 hours of ischemia; I3R10 0, 3 hours of ischemia,
followed by 10 minutes of reperfusion; I3R2, 3 hours of ischemia, followed 2 hours of reperfusion; Vmax, maximal
ﬁber mitochondrial respiration; Vsucc, activity after stimulation with succinate; Vtmpd, activity after stimulation with
N,N,N’,N’-tetramethyl-p-phenylenediamine dihydrochloride. The error bars indicate the standard error of the mean.
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The main results of this study demonstrate that:
1. There is a biphasic production of ROS, with an early
increase during ischemia alone, followed by a normal-
ization after 10 minutes reperfusion and a secondary
increase after 2 hours of reperfusion;
2. Skeletal muscle mitochondrial respiratory chain im-
pairment occurs only after 2 hours of reperfusion,
and
3. Lower limb IR leading to skeletal muscle impairment
is not associated with early mitochondrial dysfunctionin the main remote organs such as the heart, lung,
liver, kidney, or brain.
Although ROS production is thought to be a key event
during lower limb IR-induced deleterious effects, its kinetic
remains to be determined, and particularly, ROS produc-
tion during ischemia remains a debated question. Indeed,
lack of oxygen availability during ischemia should preclude
ROS formation. Thus, studies have suggested that oxidant
production does not occur during ischemia, and for
instance, no free radicals were detected during 90 minutes
of anoxia in human umbilical vein endothelial cells.
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some ROS generation occurs during ischemia.18-20
Recently, Vanden Hoek et al20 demonstrated that
cultured cardiomyocytes generate ROS during ischemia.
In fact, even after careful artery ligation, hypoxia might
not be totally complete because of residual O2 levels in
the tissue.20,21 Accordingly, ROS production has also
been observed during ischemia in the arteriolar wall.22
Consistently with these data, we observed an increased
DHE staining at the end of the 3 hours of ischemia, before
any reperfusion. The mechanisms involved in ROS produc-
tion are not totally elucidated but should not involve
mainly mitochondria that were not impaired by ischemia
alone. However, even normal mitochondria produce
ROS, and we cannot exclude that a reduced antioxidant
defense secondary to ischemia explains such an early
increase in ROS production.
The signiﬁcance of ROS generation during ischemia is
an important issue, and data clearly suggest that oxidants
generated during ischemia contribute to cell injury during
reperfusion21,23 and progressively erode cellular antioxi-
dant capacity. Although not necessarily creating immedi-
ately a lethal stress, antioxidant mechanism depletion
participates in cell injuries occurring at reperfusion. Indeed,
enhanced ROS production at reperfusion might over-
whelm the remaining antioxidant mechanisms.20,21,24
Such a mechanism might explain the beneﬁcial effects of
ROS buffering by ischemic preconditioning, which was
observed in experimental and also in clinical lower limb
ischemia.4,7,13
Interestingly and unexpectedly, we observed ROS
normalization after 10 minutes of reperfusion, although
signiﬁcant ROS production during the ﬁrst minutes of
reperfusion has generally been reported.20,25 Duration of
reperfusion might be involved because ROS burst produc-
tion likely occurs earlier, explaining that the efﬁciency of
ischemic postconditioning deeply relies on its precocity.25
ROS normalization may also suggest that muscle antioxi-
dant capacities were active and efﬁcacious during the ﬁrst
10 minutes of reperfusion.
Finally, and importantly, after 2 hours of reperfusion
following the 3 hours of ischemia, skeletal muscle DHE
staining was increased again, suggesting that ROS buff-
ering was no longer possible. This conﬁrms that enhanced
oxidative stress is likely involved in muscle impairment after
lower limb IR. At this time, complex I of the mitochondrial
respiratory chain might have participated in enhanced ROS
production because it was largely impaired and known to
participate in ROS release in the setting of IR.7,9,26 In addi-
tion, inﬂammation favors ROS production, and increased
macrophage and monocyte inﬁltration in skeletal muscled
observed in a similar settingdmight have played a role.10
Furthermore, decreased neutrophil extracellular traps
were associated with reduced hind limb IR injury.27
Taken together, these data support that ROS produc-
tion preceded skeletal muscle mitochondrial dysfunction.
Indeed, mitochondrial alterations occurred only 2 hoursafter reperfusion. Acknowledging that inhibitors of ROS
production should be used to demonstrate the cause-
and-effect of ROS production and mitochondrial dysfunc-
tion, a large body of evidence supports that ROS are largely
involved in mitochondrial dysfunction during lower limb
ischemia.6,9
We can therefore conclude that dysfunction of the skel-
etal muscle mitochondrial respiratory chain is delayed and
likely secondary to a previous ROS production. Such data
conﬁrm earlier reports from others and our group and
support that the mitochondria have a central role in IR.5-7
Further, because oxidative stress precedes skeletal
muscle mitochondrial dysfunction and arises early during
lower limb ischemia, therapy should be conducted, even
during ongoing ischemia. Thus, preconditioning being
not always feasible, particularly in the context of an emer-
gency, conditioning performed during ischemia (precondi-
tioning) might be a successful approach and deserves to be
studied.28
Remote organ alterations participate importantly in the
prognosis of patients with peripheral artery disease who
need surgery. Adembri et al2 reported that even subtle skel-
etal muscle dysfunction was associated with lung impair-
ment, leading to multiple organ failure. This was also
observed when considering renal function, and recently,
Ali et al4 reported in humans that ischemic preconditioning
reduced renal and cardiac alterations associated with aortic
clamping.2,3 This demonstrates that remote organ alter-
ation can be alleviated. We therefore determined potential
remote organ impairment and mechanisms by analyzing
histology, inﬂammation markers, biologic, and mitochon-
drial function.
No signiﬁcant histologic evidence of injury to the heart,
kidney, or liver was observed. This is consistent with
previous data supporting that a longer time of reperfusion
is needed to induce structural damage.1,29 Accordingly,
DHE staining was not increased in these organs after
2 hours of reperfusion. However, further supporting
involvement of inﬂammation, enhanced macrophage and
monocyte inﬁltration was observed in the liver. Whether
hepatic dysfunction might totally explain the ALAT and
ASAT increase is unlikely. Indeed, ALAT, ASAT, and
increased creatininemia might correspond to skeletal muscle
alterations rather than to liver or kidney injuries.30,31
To get further insights in this issue, we investigated
activities of the mitochondrial respiratory chain complexes
in the brain, heart, lung, kidney and liver after lower limb
IR, assuming that functional alterations should precede
structural alterations. No signiﬁcant impairment was
observed, whatever the mitochondrial respiratory chain
complex or organ studied.
Such a precise analysis at the mitochondrial level has
never been reported before and suggests that remote organ
alteration did not begin that early at such a subcellular
level. Our results may be explained by the relatively short
reperfusion period, mitochondrial alterations in remote
organs relying partly on inﬂammation that possibly needs
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methods, or both.27,32,33
CONCLUSIONS
The activities of the mitochondrial respiratory chain
complexes of brain, lung, kidney, heart, and liver were
not impaired after 3 hours of aortic clamping and 2 hours
of reperfusion. However, skeletal muscle IR was associ-
ated with an early local production of ROS and later
with mitochondrial dysfunction. Such a kinetic, described
for the ﬁrst time, supports that reducing signiﬁcantly ROS
release, even during ischemia, should result in better
muscle protection. Thus, therapy should be conducted
early in the setting of lower limb ischemia, and because
preconditioning is not always feasible, studies are needed
to determine whether ischemic preconditioning might be
a successful approach.
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Detection of reactive oxygen species. To detect the
presence of reactive oxygen species (ROS) in skeletal
muscle, heart, kidney, and liver, serial 10-mm sections
were cut on a cryostat microtome, mounted onto glass
slides, and incubated with 2.5 mmol/L of dihydroethidium
(DHE).14 DHE was used in heart, kidney, and liver only in
the sham and the I3R2 (ischemia for 3 hours, followed by
reperfusion for 2 hours) groups at the end of the experi-
ment. In skeletal muscle, DHE was used in the four groups
at the end of the experiment. DHE produces red ﬂuores-
cence when oxidized to ethidium bromide by ROS,
including superoxide anion.15 After staining, sections
were examined under an Eclipse E800 epiﬂuorescence
microscope (Nikon, New York, NY), and the emission
signal was recorded with a Zeiss 573-637-nm ﬁlter (Carl
Zeiss, Oberkochen, Germany). Pictures taken with the
microscope were analyzed with Photoshop CS2 image pro-
cessing software (Adobe Systems, San Jose, Calif).
Immunohistochemical procedure. To detect inﬂam-
mation in heart, kidney, and liver in the sham and I3R2
groups at the end of the experiment, we used monocyte
macrophage-2 (Millipore, Billerica, Mass) antibody on
10-mm-thick serial sections of tisuse.10 Brieﬂy, muscle
sections were air dried and then ﬁxed in paraformaldehyde
4% for 3 minutes. The sections were placed in a 2% solution
of hydrogen peroxide for 5 minutes, which served to
reduce endogenous or pseudoperoxidase background
staining. Primary antibody was used at predetermined
optimal dilutions. A standard indirect immunoperoxidaseprocedure, using biotinylated goat antirat antibody (Milli-
pore) and streptavidin-horseradish peroxidase (Millipore),
was used to detect binding of monocyte macrophage-2.
The slides were developed by diaminobenzidine substrate.
Tissues were counterstained brieﬂy with hematoxylin and
eosin before mounting.
Permeabilization of muscle and heart ﬁbers. Mito-
chondrial respiration was studied in saponin-skinned ﬁbers,
as previously described.16,17 Brieﬂy, ﬁbers were separated,
permeabilized, in a bath of solution containing 50 mg/mL
saponin for 30 minutes at 4C, under shaking. The permea-
bilized ﬁbers were then washed for 10 minutes under
shaking to remove saponin. Fibers were placed in a bath
with the respiratory solution for 5 minutes twice to remove
any phosphates.
Isolation of mitochondria in lung, heart, brain, liver,
and kidney. Lung, heart, brain, liver, and kidney mitochon-
dria were isolated on ice from animals. Tissue was placed in
isolation buffer containing 70 mM sucrose, 210 mM
mannitol, and 1 mM ethylene glycol tetraacetic acid in
50 mM Tris/HCl (pH 7.4). The tissue was ﬁnely minced
with scissors and then homogenized in the same buffer using
a tissue grinder. The homogenate was centrifuged at
3000 rpm for 3 minutes at 4C and the resultant supernatant
at 10,000 rpmfor10minutes at 4C.Themitochondrial pellet
was washed in isolation buffer containing 70 mM sucrose
and 210 mMmannitol in 50 mM Tris/HCl (pH 7.4) before
being resuspended in this buffer. Aliquots were then removed
for proteinmeasurement by theBradfordmethod (Biomate3;
Thermo Fisher Scientiﬁc Inc, Waltham, Mass).
Supplementary Fig 1 (online only). Top, Schematic represen-
tation shows the mitochondrial respiratory chain with speciﬁc
substrates and inhibitors. ADP, adenosine diphosphate; I, complex
I (nicotinamide adenine dinucleotide reductase [NADH]-
coenzyme Q [CoQ] reductase); II, complex II (succinate-CoQ
reductase); III, complex III (CoQH2-c reductase); IV, complex
IV (cytochrome-c oxidase, COX); V, adenosine triphosphate
(ATP) synthase; TMPD, N,N,N’,N’-tetramethyl-p-phenylenedi-
amine dihydrochloride. Bottom, Schematic oxygraph trace shows
oxygen consumption by the permeabilized skeletal myoﬁbers,
using indicated substrates and inhibitors: Vo, before ADP; Vmax,
complexes I, III, IV activities, using glutamate and malate; Vsucc,
complexes II, III, IV activities, using succinate; VTMPD, complex
IV activity using TMPD/ascorbate.
Supplementary Fig 2 (online only). Lactate production after an
ischemia of 3 hours. The error bars indicate the standard error of
the mean. I3, 3 hours of ischemia; I3R10 0, 3 hours of ischemia,
followed by 10 minutes of reperfusion; I3R2, 3 hours of ischemia,
followed 2 hours of reperfusion.****P < .0001.
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Supplementary Fig 3 (online only). Dihydroethidium (DHE) ﬂuorescence intensity (expressed as percentage of
sham). Ischemia for 3 hours, followed by 2 hours of reperfusion (I32H) does not enhance reactive oxygen species
(ROS) production in (A) heart, (B) kidney and (C) liver.
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Supplementary Fig 4 (online only). Compared with sham, 3 hours of ischemia and 2 hours of reperfusion (I3R2) of
skeletal muscle activates inﬂammation in (C) liver but not (A) in heart or (B) kidney (original magniﬁcation 200).
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Supplementary Fig 5 (online only). Three hours of ischemia, followed by 2 hours of reperfusion (I3R2), increases
circulating (a) aspartate aminotransferase (ASAT), (b) alanine aminotransferase (ALAT), and (c) serum creatinine. The
error bars indicate the standard error of the mean. **P < .01; ***P < .001; ****P < .0001.
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